Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

REGENXBIO Inc. Director's Dealing 2015

Sep 22, 2015

32827_dirs_2015-09-22_fb34fe36-6c29-4d01-9580-7e52ffcc47c1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REGENXBIO Inc. (RGNX)
CIK: 0001590877
Period of Report: 2015-09-22

Reporting Person: ENGLEMAN EDGAR (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-09-22 Common Stock C 826341 Acquired 826341 Indirect
2015-09-22 Common Stock C 114108 Acquired 114108 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-09-22 Series D Preferred Stock $ C 826341 Disposed Common Stock (826341) Indirect
2015-09-22 Series D Preferred Stock $ C 114108 Disposed Common Stock (114108) Indirect

Footnotes

F1: Each share of Preferred Series D Stock is convertible and will automatically convert on a 1:1 basis into the Issuer's common stock upon the closing of the Issuer's initial public offering of common stock pursuant to an effective registration statement filed with the U.S. Securities and Exchange Commission. These shares have no expiration date.

F2: The Reporting Person is a managing member of Vivo Capital VIII, LLC which is the sole general partner of Vivo Capital Fund VIII, L.P., the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise or such portion of the shares of common stock of the Issuer held by Vivo Capital Fund VIII, L.P. in which the Reporting Person has no pecuniary interest.

F3: The Reporting Person is a managing member of Vivo Capital VIII, LLC which is the sole general partner of Vivo Capital Surplus Fund VIII, L.P., the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise or such portion of the shares of common stock of the Issuer held by Vivo Capital Surplus Fund VIII, L.P. in which the Reporting Person has no pecuniary interest.